- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DND PharmaTech Inc (347850)
Track today's live DND PharmaTech (347850) share price, performance and key data on this page with our current KOSDAQ:347850 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the DND PharmaTech share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 347850 share price, head to our technical summary section, which provides analysis on DND PharmaTech share price buy/sell indicators using real-time data (or discuss the DND PharmaTech (347850) stock price today with other investors in the DND PharmaTech KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:347850 share price (ISIN: KR7347850000) to enhance your trading decisions with our free investment tools and resources.
What Is the DND PharmaTech Inc Share Price Today?
The DND PharmaTech share price today is 111,200.
What Is the Stock Symbol for DND PharmaTech Inc
The stock symbol (or 'ticker') for DND PharmaTech Inc is "347850."
What Stock Exchange Does DND PharmaTech Inc Trade On?
DND PharmaTech Inc is listed and trades on the KOSDAQ stock exchange.
Is DND PharmaTech Inc a Good Stock to Buy?
Determining whether DND PharmaTech (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:347850 share price (ISIN: KR7347850000) to enhance your trading decisions with our free investment tools and resources.
What Is the DND PharmaTech Inc Share Price Today?
The DND PharmaTech share price today is 111,200.
What Is the Stock Symbol for DND PharmaTech Inc
The stock symbol (or 'ticker') for DND PharmaTech Inc is "347850."
What Stock Exchange Does DND PharmaTech Inc Trade On?
DND PharmaTech Inc is listed and trades on the KOSDAQ stock exchange.
Is DND PharmaTech Inc a Good Stock to Buy?
Determining whether DND PharmaTech (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
111,200
+2,900(+2.68%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103,200
115,800
52 wk Range
27,825
200,500
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103,200115,800
52 wk Range
27,825200,500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
347850 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
15/05/2026
EPS / Forecast
-217.71 / --
Revenue / Forecast
128.78M / --
Compare 347850 to Peers and Sector
Metrics to compare | 347850 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship347850PeersSector | |
|---|---|---|---|---|
P/E Ratio | −210.0x | −20.7x | −0.4x | |
PEG Ratio | - | −0.56 | 0.00 | |
Price/Book | 65.4x | 3.0x | 2.6x | |
Price / LTM Sales | 1,616.7x | 29.9x | 3.0x | |
Upside (Analyst Target) | - | 57.3% | 58.3% | |
Fair Value Upside | Unlock | 19.4% | 8.3% | Unlock |
D&D Pharmatech Inc. engages in the research and development and manufacturing of pharmaceuticals in South Korea. It develops oral peptides, such as MET-002o, MET-224o, MET-097o, DD03, DD07, and DD14 programs for obesity indications in the development phase; injectable peptides, including DD01 for MASH indications; NLY12 and DD15 for obesity indications; and Pegsebrenatide (NLY01) for Parkinson’s and Alzheimer’s diseases. The company is also involved in the development of TLY012, an injectable protein for systemic sclerosis, liver fibrosis, and chronic pancreatitis indications; NLY02, an oral small molecule for PD and AD indications; and P4M01 for anti-microbial peptide indications. In addition, it develops PMI07, PMI05, and PMI06 for solid tumor imaging biomarker indications; and PMI04 for neuroinflammation indications. The company was founded in 2014 and is based in Seongnam-si, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the DND PharmaTech (KOSDAQ: 347850) Share Price Today?
The DND PharmaTech stock price today is 111,200 KRW.
What Stock Exchange Does DND PharmaTech (347850) Trade On?
DND PharmaTech is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for DND PharmaTech?
The stock symbol (also called a 'ticker') for DND PharmaTech is "347850."
What Is the Current DND PharmaTech Market Capitalisation?
As of today, DND PharmaTech (KOSDAQ: 347850) market cap is 4.87T KRW.
What Is DND PharmaTech's (347850) Earnings Per Share (TTM)?
The DND PharmaTech EPS is currently -535 (Trailing Twelve Months).
Is 347850 a Buy or Sell From a Technical Analyst Perspective?
Based on today's DND PharmaTech moving averages and other technical indicators, the daily buy/sell signal for 347850 stock is Strong Buy.
How Many Times Has DND PharmaTech Stock Split?
DND PharmaTech has split 1 times. (See the 347850 stock split history page for full effective split date and price information.)
What is the current trading status of DND PharmaTech (KOSDAQ: 347850)?
As of 19/06/2026, DND PharmaTech (347850) is trading at a share price of 111,200 KRW, with a previous close of 108,300 KRW. The stock has fluctuated within a day range of 103,200 KRW to 115,800 KRW, while its 52-week range spans from 27,825 KRW to 200,500 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.